Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced a conference call set for May 10, 2023, at 8:30 AM ET, following the release of its first-quarter financial results for 2023. The call will feature key executives including Kim Rivers (CEO), Alex D'Amico (CFO), and Steve White (President), who will discuss the company's financial performance and operational outcomes. Interested participants can join the call via a dedicated toll-free number and passcode, or through a live audio webcast. An archived version of the webcast will also be accessible post-event on Trulieve's investor relations page. Trulieve continues to strengthen its market presence as a leading cannabis company across various U.S. regions, focusing on growth through retail and distribution expansion.
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF), a leading U.S. cannabis company, announced its participation in the Benzinga Cannabis Capital Conference on April 11-12, 2023. Chief Marketing Officer Gina Collins will join a panel discussion on April 11 at 10:10 AM. Trulieve operates in multiple states, including Arizona, Florida, and Pennsylvania, focusing on growth and customer experience through a hub strategy. The company's established market positions aim to increase access to high-quality cannabis products. For more details about their event participation, visit Trulieve's events page.
Trulieve Cannabis Corp. announced the grand opening of a new medical dispensary in Palatka, Florida, on March 8, 2023. The dispensary, located at 101 North Highway 17, will operate from 9 a.m. to 9 p.m., Monday to Saturday, and from 10 a.m. to 8 p.m. on Sundays. To celebrate the opening, registered patients will receive a 30% discount along with various giveaways and activities throughout the day. Trulieve continues to lead Florida's medical cannabis market, offering the largest selection of THC and CBD products, and providing home delivery and online orders. The company aims to enhance patient access and customer experience.
Trulieve Cannabis Corp. (TCNNF) reported record revenue of $1.24 billion in 2022, a 32% increase year-over-year. Q4 revenue was $302 million, with a 2% sequential retail growth. The company operates 181 dispensaries across 11 states, expanding its footprint by 14%. Fourth quarter results included a GAAP gross margin of 50% and an adjusted EBITDA of $85 million. Despite these successes, Trulieve faced a net loss of $77 million and an adjusted net loss of $35 million. The company aims for cash generation while pursuing growth opportunities within the U.S. cannabis market.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
